InDex Pharmaceuticals' Series A Round

InDex Pharmaceuticals raised a round of funding on January 21, 2011.

InDex Pharmaceuticals develops Kappaproct - a completely new type of drug that can help patients with severe ulcerative colitis back to a normal life. The results from an ongoing Phase III study are e…

Articles about InDex Pharmaceuticals' Series A Round: